| 1 |
NCT03137680 |
Not yet recruiting |
Pre-Operative Forearm Exercise On Arteriovenous Fistula Mauration |
|
- Behavioral: Hand Exercise
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Single (Care Provider)
- Primary Purpose: Treatment
|
- Hemodynamics in the fistula artery and vein, pre and post AV fistula formation
- Suitability of cannulation of AV fistula
- Secondary fistula failure
|
40 |
All |
21 Years to 90 Years (Adult, Senior) |
NCT03137680 |
2016/2573 |
|
May 15, 2017 |
December 15, 2018 |
March 20, 2019 |
May 3, 2017 |
May 3, 2017 |
|
|
| 2 |
NCT02880761 |
Recruiting |
Cohort Study on A Following-up System of Native Arteriovenous Fistulae |
|
- Procedure: Assessment guiding surgery and puncture for AVF
|
Interventional |
Not Applicable |
- Capital Medical University
- Peking University International Hospital
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Primary Failure of AVF
- Life time of AVF
|
200 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT02880761 |
2016-019 |
|
July 2016 |
July 2018 |
May 2019 |
August 26, 2016 |
August 30, 2016 |
|
- Peking University International Hospital
Beijing, Beijing, China
|
| 3 |
NCT01512927 |
Unknown † |
Electro Stethoscope in Detect Arteriovenous Fistula (AVF) Stenosis |
|
|
Observational |
|
- National Taiwan University Hospital
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
|
150 |
All |
20 Years to 90 Years (Adult, Senior) |
NCT01512927 |
201112015RIC |
|
January 2012 |
November 2012 |
December 2012 |
January 19, 2012 |
January 19, 2012 |
|
- National Taiwan University Hospital
Taipei, Taiwan
|
| 4 |
NCT01806545 |
Completed
Has Results |
An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access |
|
- Biological: SRM003
- Other: Participating Site's standard practice
|
Interventional |
Phase 2 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Percentage of Participants With Arteriovenous Fistula (AVF) Maturation by Week 12 Visit Based on Hemodialysis or Color-flow Doppler Ultrasound (CDUS) And Vascular Access Examination
- Percentage of Participants With AVF Maturation by Week 26 Visit Based on Hemodialysis or CDUS And Vascular Access Examination
- Time to AVF Maturation Based on Hemodialysis or CDUS and Vascular Access Examination
- (and 6 more...)
|
64 |
All |
18 Years and older (Adult, Senior) |
NCT01806545 |
AVF01-SRM003 |
|
March 2013 |
October 2014 |
October 2014 |
March 7, 2013 |
December 24, 2015 |
December 24, 2015 |
- Akdhc Medical Research Services
Phoenix, Arizona, United States - Tucson Vascular Consultants
Tucson, Arizona, United States - Ladenheim Dialysis Access Center
Fresno, California, United States - (and 44 more...)
|
| 5 |
NCT03171701 |
Not yet recruiting |
Color Doppler Ultrasonography in Prediction of Arteriovenous Fistula Maturation in Hemodialysis Patients |
|
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Other
|
- Role of color Doppler ultrasonography in prediction of arteriovenous fistula maturation and its complications in hemodialysis patients
|
30 |
All |
Child, Adult, Senior |
NCT03171701 |
arteriovenous fistula |
|
July 1, 2017 |
July 1, 2018 |
October 1, 2018 |
May 31, 2017 |
June 8, 2017 |
|
|
| 6 |
NCT02305992 |
Withdrawn |
Regional Anesthesia for Arteriovenous Fistula |
|
- Procedure: Axillary Block with 0.5% Ropivicaine
- Procedure: Stellate ganglion block with 0.2% Ropivicaine
- Procedure: Local anesthetic infiltration with 0.25% Bupivicaine
|
Interventional |
Not Applicable |
- McMaster University
- St. Joseph's Healthcare Hamilton
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Arteriovenous fistula flow
- Change in limb temperature pre-anesthetic and post-anesthetics
- Duration of intraoperative procedure
- (and 4 more...)
|
0 |
All |
18 Years to 65 Years (Adult) |
NCT02305992 |
14-123 |
|
December 2015 |
December 2017 |
December 2017 |
December 3, 2014 |
March 21, 2018 |
|
- St. Joseph's Healthcare Hamilton
Hamilton, Ontario, Canada
|
| 7 |
NCT01642459 |
Terminated |
The Outcomes of Arteriovenous Fistula Cannulated From Different Direction. |
|
- Other: Same direction cannulation
- Other: Opposite direction cannulation
|
Interventional |
Not Applicable |
- Dongliang Zhang, MD
- Capital Medical University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Prevalence of AVF aneurysm and stenosis.
- Proportions of AVF dysfunction in different groups.
- The size of venous aneurysm.
- (and 3 more...)
|
10 |
All |
18 Years to 85 Years (Adult, Senior) |
NCT01642459 |
2012-0107 |
|
September 2012 |
April 2013 |
April 2013 |
July 17, 2012 |
May 20, 2015 |
|
- Beijing Friedship Hospital
Beijing, Beijing, China
|
| 8 |
NCT02493504 |
Completed |
Effects of Heparin on Arteriovenous Fistula Patency |
|
|
Interventional |
Phase 4 |
- Fatemeh Hoseinzadegan
- Shahid Beheshti University of Medical Sciences
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- The number of patients with a bruit auscultated over AVF
|
150 |
All |
Child, Adult, Senior |
NCT02493504 |
SHBMU-001124 |
|
January 2011 |
April 2012 |
January 2013 |
July 9, 2015 |
July 9, 2015 |
|
|
| 9 |
NCT02180945 |
Completed |
ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae |
|
|
Observational |
|
- Medtronic Neurovascular Clinical Affairs
|
Industry |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Neurological clinical evolution
- Healing rate
- Adverse event
- (and 3 more...)
|
110 |
All |
18 Years to 99 Years (Adult, Senior) |
NCT02180945 |
NV-ONY-001 |
dAVF |
July 2013 |
May 2016 |
May 2016 |
July 3, 2014 |
March 9, 2018 |
|
|
| 10 |
NCT02447796 |
Unknown † |
Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery |
|
- Drug: Propofol
- Drug: Dexmedetomidine
|
Interventional |
Phase 4 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Care Provider, Investigator)
- Primary Purpose: Treatment
|
- The incidence of adverse effects such as respiratory and hemodynamic events
- The sedation onset time with using BIS and recovery times during the procedure.
|
48 |
All |
20 Years to 70 Years (Adult, Senior) |
NCT02447796 |
KA 15/60 |
|
May 2015 |
May 2015 |
July 2015 |
May 19, 2015 |
May 19, 2015 |
|
- Baskent University School of Medicine Adana Research and Teaching Center
Adana, Turkey
|
| 11 |
NCT03188978 |
Not yet recruiting |
High-intensity Atorvastatin for Arteriovenous Fistula Failure (HAFF): A Feasibility Pilot Study |
- Primary Arteriovenous Fistula Failure
|
- Drug: Atorvastatin 40mg
- Other: Placebo
|
Interventional |
Phase 1
Phase 2 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Patient recruitment rate (in percent)
- Patient retention rate (in percent)
- Patient compliance (in percent)
- (and 3 more...)
|
50 |
All |
19 Years and older (Adult, Senior) |
NCT03188978 |
HAFF |
HAFF |
January 1, 2018 |
December 31, 2019 |
December 31, 2019 |
June 16, 2017 |
October 11, 2017 |
|
- Albany Medical College
Albany, New York, United States
|
| 12 |
NCT03213756 |
Recruiting |
Isometric Preoperative Exercise on Autologous Arteriovenous Fistulas. Randomized Clinical Trial |
- Arteriovenous Fistula Thrombosis
- Arteriovenous Fistula Stenosis
|
- Device: Isometric exercises using Hand grip and elastic bands
|
Interventional |
Not Applicable |
- Hospital General Universitario Gregorio Marañon
- SEN (Spanish Society of Nephrology)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Impact of PIE on AVF primary failure comparing the control group and the PIE group.
- Percentage of candidate patients for autologous distal or proximal AVF in both groups.
- Differences on the caliber of upper arm arteries and veins in the PIE group before and after isometric exercise.
- (and 3 more...)
|
158 |
All |
18 Years to 95 Years (Adult, Senior) |
NCT03213756 |
PHYSICALFAV |
PHYSICALFAV |
July 18, 2017 |
July 5, 2019 |
October 5, 2019 |
July 11, 2017 |
July 31, 2017 |
|
- Hospital Gregorio Marañon
Madrid, Spain
|
| 13 |
NCT01669850 |
Terminated |
Clipped Versus Handsewn Arteriovenous Fistula Anastomosis |
- Arteriovenous Fistula Complications and Failure
|
- Device: Clipped anastomosis
- Procedure: Handsewn anastomosis
|
Interventional |
Not Applicable |
- Gundersen Lutheran Medical Foundation
- Gundersen Lutheran Health System
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Patency rates
- Surgical complications
|
38 |
All |
18 Years and older (Adult, Senior) |
NCT01669850 |
2-12-07-002 |
|
August 2012 |
December 2014 |
December 2014 |
August 21, 2012 |
September 7, 2015 |
|
- Gundersen Lutheran Health System
La Crosse, Wisconsin, United States
|
| 14 |
NCT03355508 |
Recruiting |
Impact of the Arteriovenous Fistula Puncture Technique On the Hemodialysis Session For Patient and Caregiver |
- Arterio-venous Fistula, Puncture, Chronic Desease
|
- Device: pucture in the arteriovenous fistula
|
Interventional |
Not Applicable |
- Poissy-Saint Germain Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Supportive Care
|
- Compression time required for hemostasis
|
42 |
All |
18 Years and older (Adult, Senior) |
NCT03355508 |
TECHFAVHEMO |
|
September 29, 2017 |
September 2020 |
February 2021 |
November 28, 2017 |
November 28, 2017 |
|
- CH Poissy st Germain
Poissy, France
|
| 15 |
NCT03024372 |
Recruiting |
Continuous Suturing Versus Interrupted Clips for Brachiocephalic AV Fistula Creation |
|
- Device: AV Fistula creation with sutures
- Device: AV Fistula creation with clips
|
Interventional |
Not Applicable |
- University of South Florida
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Time to loss of primary patency
- Time to loss of secondary patency
- Time to loss of assisted primary patency
- (and 8 more...)
|
164 |
All |
18 Years and older (Adult, Senior) |
NCT03024372 |
Sutures vs Clips AVF |
|
December 2017 |
February 2024 |
August 2024 |
January 18, 2017 |
October 26, 2017 |
|
- Tampa General Hospital
Tampa, Florida, United States - University of South Florida - South Tampa Campus
Tampa, Florida, United States - USF Health Carol and Frank Morsani Center for Advanced Healthcare
Tampa, Florida, United States
|
| 16 |
NCT02440022 |
Active, not recruiting |
Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae |
|
- Combination Product: Lutonix DCB
- Device: Standard Balloon Angioplasty Catheter
- Procedure: Percutaneous Transluminal Angiography
|
Interventional |
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Efficacy: Primary Patency
- Safety: Freedom from any serious adverse event(s) involving the AV access circuit.
- Target Lesion Primary Patency
- (and 6 more...)
|
285 |
All |
21 Years and older (Adult, Senior) |
NCT02440022 |
CL0023-01 |
|
June 2015 |
September 2016 |
May 2018 |
May 12, 2015 |
March 26, 2018 |
|
- The Board of Trustees of The University of Alabama for the University of Alabama at Birmingham
Birmingham, Alabama, United States - Arizona Kidney Disease and Hypertension Center Medical Research Services, LLC
Phoenix, Arizona, United States - Southwest Clinical Research Institute, LLC
Tempe, Arizona, United States - (and 20 more...)
|
| 17 |
NCT01748422 |
Recruiting |
Qutenza (Topical Capsaicin 8%) for Painful Arteriovenous Fistulae |
- Neuropathic Pain
- Arteriovenous Fistulae
|
|
Observational |
|
- NHS Greater Glasgow and Clyde
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Neuropathic pain
- Quality of life
- Safety and tolerability
|
20 |
All |
18 Years to 100 Years (Adult, Senior) |
NCT01748422 |
GU11SB126 |
|
November 2015 |
August 2017 |
August 2017 |
December 12, 2012 |
November 11, 2016 |
|
- Department of Renal Surgery, Queen Elizabeth University Hospital
Glasgow, Lanarkshire, United Kingdom
|
| 18 |
NCT02753998 |
Recruiting |
Paclitaxel-coated Balloon Angioplasty Versus Standard Angioplasty for the Treatment of Stenosis of Arteriovenous Fistula |
- Angioplasty
- Stenosis of Arteriovenous Fistula
|
- Device: Additional angioplasty with paclitaxel-coated balloon
- Device: Additional angioplasty with placebo balloon
- Procedure: Conventional angioplasty
|
Interventional |
Phase 3 |
- Assistance Publique - Hôpitaux de Paris
- Bard Peripheral Vascular (balloons provider)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Proportion of patients with primary patency of AVF
- Rate of restenosis > 50% at the site of angioplasty
- Proportion of patients deteriorating back to preoperative flow of arteriovenous fistula
- (and 4 more...)
|
150 |
All |
18 Years and older (Adult, Senior) |
NCT02753998 |
P150908 |
ABISS |
December 2016 |
December 2019 |
December 2019 |
April 28, 2016 |
October 13, 2017 |
|
- Service chirurgie vasculaire, Hôpital Ambroise Paré
Boulogne-Billancourt, Hauts-de-Seine, France
|
| 19 |
NCT02632942 |
Recruiting |
Criteria for Accessory Vein Obliteration Trial. |
- Arteriovenous Fistula Maturation Failure
|
- Procedure: HAQ criteria
- Procedure: Current Recommendation
|
Interventional |
Not Applicable |
- King Faisal Specialist Hospital & Research Center
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Maturation of AVF
- Primary Patency
- Secondary Patency
|
50 |
All |
18 Years and older (Adult, Senior) |
NCT02632942 |
2141 125 |
CAVO |
September 2015 |
September 2018 |
December 2018 |
December 17, 2015 |
October 4, 2016 |
|
- King Faisal Specialist Hospital & Research Center
Riyadh, Saudi Arabia
|
| 20 |
NCT03366727 |
Not yet recruiting |
AcoArt III / AVF China |
- Arteriovenous Fistula Stenosis
|
- Device: drug-coated balloon catheter （Orchid, Acotec）
- Device: plain balloon catheter (Admiral, medtronic)
|
Interventional |
Not Applicable |
- Acotec Scientific Co., Ltd
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- primary patency of target lesion in 12 months
- primary patency of target lesion in 6 months
- number of reinterventions
- (and 3 more...)
|
172 |
All |
18 Years to 85 Years (Adult, Senior) |
NCT03366727 |
Acotec-05 |
|
February 1, 2018 |
March 1, 2020 |
September 1, 2020 |
December 8, 2017 |
December 8, 2017 |
|
- Chinese PLA General Hospital
Beijing, Beijing, China - Tongren hospital, Capital medical university
Beijing, Beijing, China - The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing, China - (and 8 more...)
|
| 21 |
NCT02746159 |
Active, not recruiting |
Lutonix® Global AV Registry |
|
- Device: Lutonix 035 Drug Coated Balloon PTA Catheter, Model 9004
|
Observational |
|
|
Industry |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- Proportion of subjects with freedom from any serious adverse event(s) involving the AV access circuit
- Proportion of subjects with target lesion primary patency
- Proportion of subjects with access circuit primary patency at 3, 6, and 12 months
- (and 6 more...)
|
324 |
All |
18 Years and older (Adult, Senior) |
NCT02746159 |
CL0026-01 |
AVR |
June 2016 |
September 2018 |
March 2019 |
April 21, 2016 |
March 6, 2018 |
|
- LKH Graz
Graz, Austria - Clinique du Pré
Le Mans, France - Clinique Les Fontaines
Melun, France - (and 15 more...)
|
| 22 |
NCT02565953 |
Recruiting |
Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon |
- Arteriovenous Fistula Renal Dialysis Devices Obstruction
|
- Device: Paclitaxel-releasing PTA balloon catheter
- Device: PTA balloon catheter
|
Interventional |
Phase 3 |
- Fundación Pública Andaluza Progreso y Salud
- Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Freedom from target lesion revascularization
|
134 |
All |
18 Years and older (Adult, Senior) |
NCT02565953 |
FISBAL |
FISBAL |
October 2015 |
October 2017 |
October 2018 |
October 1, 2015 |
November 22, 2017 |
|
- Hospital Universitario Puerto Real
Puerto Real, Cádiz, Spain - Hospital Universitario Reina Sofía
Córdoba, Spain - Hospital Universitario Virgen de las Nieves
Granada, Spain - Hospital Universitario Juan Ramón Jiménez
Huelva, Spain
|
| 23 |
NCT02902094 |
Recruiting |
Drug Eluting Balloon Venoplasty in AV Fistula Stenosis |
- Native Arteriovenous Fistula
- Stenosis
|
- Device: Drug eluting balloons
- Device: Non drug eluting balloons
|
Interventional |
Not Applicable |
- University Hospital Birmingham
- Boston Scientific Corporation
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Patency
- Technical success
- Assisted technical success of balloon angioplasty
- (and 2 more...)
|
186 |
All |
18 Years and older (Adult, Senior) |
NCT02902094 |
RRK5479 |
DeVA |
January 2016 |
January 2019 |
January 2019 |
September 15, 2016 |
September 15, 2016 |
|
- University Hospitals Birmingham NHS Foundation Trust
Birmingham, West Midlands, United Kingdom
|
| 24 |
NCT03106948 |
Recruiting |
Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis |
- Arteriovenous Fistula Occlusion
|
- Drug: Placebo
- Drug: Ascorbic Acid
- Drug: Cuprimine Oral Product
|
Interventional |
Phase 2 |
- Southeast Renal Research Institute
- Dialysis Clinic, Inc.
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Patients treated with ascorbic acid in combination with D-penicillamine will have longer periods between serial angioplasties over 12-month period. Additionally, subjects receiving combination therapy may have greater post-angioplasty luminal diameters.
|
30 |
All |
18 Years to 90 Years (Adult, Senior) |
NCT03106948 |
Lysyl Oxidase (LysoLox) |
|
February 1, 2017 |
January 31, 2018 |
March 2018 |
April 11, 2017 |
September 11, 2017 |
|
- Southeast Renal Research Institute
Chattanooga, Tennessee, United States
|
| 25 |
NCT02874391 |
Recruiting |
Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients |
- Evaluate the Risks of Using Arteriovenous Fistula as First Choise for Drug Administration
|
|
Observational |
|
- University Hospital, Angers
|
Other |
- Observational Model: Other
- Time Perspective: Prospective
|
- Evaluate the risk of complications of AV fistula
|
50 |
All |
18 Years and older (Adult, Senior) |
NCT02874391 |
PHRIP-15-633 |
PerFAV |
September 2016 |
September 2019 |
September 2019 |
August 22, 2016 |
January 20, 2017 |
|
|
| 26 |
NCT02705417 |
Completed |
Maximizing Native Arteriovenous Fistulae Rates. |
- Kidney Failure
- Arteriovenous Shunt
- Hemodialysis
|
- Procedure: preoperative color Doppler ultrasonographic vascular mapping
- Procedure: physical examination
- Procedure: medical history
- (and 2 more...)
|
Observational |
|
- Medifil AE
- International Renal Research Institute Vicenza
|
Other |
- Observational Model: Cohort
- Time Perspective: Retrospective
|
- number of native AVF constructed
- primary patency rates
|
136 |
All |
Child, Adult, Senior |
NCT02705417 |
1 |
|
January 2012 |
January 2014 |
January 2015 |
March 10, 2016 |
March 10, 2016 |
|
|
| 27 |
NCT03044496 |
Completed |
NIRS Measurement After SCP Block |
|
- Drug: Supraclavicular nerve block
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- NIRS after block
- Difference between both arms
|
15 |
All |
18 Years and older (Adult, Senior) |
NCT03044496 |
NIRS after SCP block |
|
September 2016 |
September 2017 |
January 2018 |
February 7, 2017 |
April 12, 2018 |
|
- Marienhospital Stuttgart, Dpt. of Anaesthesiology
Stuttgart, Baden Württemberg, Germany
|
| 28 |
NCT02453412 |
Enrolling by invitation |
Preoperative Arteriovenous Fistula Simulation Study (ShuntSimulationStudy) |
- Kidney Failure, Chronic
- Arteriovenous Fistulae
|
|
Interventional |
Phase 2
Phase 3 |
- Maastricht University Medical Center
- Maastricht University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Occurence of non-maturation
- Occurence of high-flow complications
- Primary patency rates
- (and 3 more...)
|
236 |
All |
18 Years and older (Adult, Senior) |
NCT02453412 |
NT12.01
NL51610.068.14 |
3S |
May 2015 |
May 2019 |
May 2019 |
May 25, 2015 |
April 4, 2018 |
|
- Flevoziekenhuis
Almere, Flevoland, Netherlands - Maasstad Ziekenhuis
Rotterdam, Zuid-Holland, Netherlands - Slingeland ziekenhuis
Doetinchem, Netherlands - (and 6 more...)
|
| 29 |
NCT01099189 |
Unknown † |
Vein Histology in Arteriovenous Fistulas and Its Effect on Fistula Surgery Success |
- Renal Replacement Therapy
- Arteriovenous Fistula
|
|
Observational |
|
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- - Primary failure of access[10] - Immediate/early thrombosis or failure to mature.
- - Duplex findings of evidence of stenosis and correlation to compliance or histological findings
- - Correlation between biomechanical compliance and histological measures of pre existing venous pathology
- (and 3 more...)
|
30 |
All |
18 Years and older (Adult, Senior) |
NCT01099189 |
Access 4 |
|
July 2010 |
March 2011 |
September 2011 |
April 6, 2010 |
April 6, 2010 |
|
- Academic Vascular Surgery Unit
Hull, Yorkshire, United Kingdom
|
| 30 |
NCT02297451 |
Recruiting |
Trial Comparing the Incidence of Steal Syndrome in the Two Types of anTEcubitaL Fossa Arteriovenous fistuLa AVF |
- Arteriovenous Fistulas
- Renal Failure, End-Stage
- Steal Syndrome
|
- Procedure: Proximal radial/ulnar artery as inflow
|
Interventional |
Not Applicable |
- Cambridge University Hospitals NHS Foundation Trust
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Prevention
|
- Incidence of steal syndrome as measured by Hoek Score
- Presence of severe steal syndrome necessitating surgical revision/ligation
- Operative time
- Utilisation of fistula
|
110 |
All |
18 Years to 100 Years (Adult, Senior) |
NCT02297451 |
A091982
10/H0308/90 |
STEAL |
February 2011 |
December 2017 |
December 2017 |
November 21, 2014 |
July 17, 2017 |
|
- Addenbrooke's Hospital
Cambridge, United Kingdom
|
| 31 |
NCT01863914 |
Recruiting |
Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula |
- End-stage Kidney Disease
- Diabetes Mellitus
- Arteriovenous Fistula
|
|
Interventional |
Phase 2 |
- National Cheng-Kung University Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Primary patent rate of AV fistula
- Composite outcome measurement of the overall shunt-related complication rate
|
80 |
All |
18 Years to 65 Years (Adult) |
NCT01863914 |
101-2314-B-006-045 |
|
November 2012 |
December 2018 |
December 2018 |
May 29, 2013 |
October 17, 2017 |
|
- National Cheng Kung University Hospital
Tainan, Taiwan
|
| 32 |
NCT01391975 |
Unknown † |
Surveillance and Proactive Intervention for Dialysis Access |
- Renal Failure
- Arteriovenous Fistula
|
- Procedure: Active ultrasound surveillance of fistula and proactive treatment of stenosis
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Cumulative or secondary patency
- Number of thrombosis events
- Number of fistula failures
- (and 2 more...)
|
850 |
All |
18 Years and older (Adult, Senior) |
NCT01391975 |
Access 6 |
SPIDA |
May 2012 |
May 2014 |
October 2014 |
July 12, 2011 |
July 12, 2011 |
|
- Hull Royal Infirmary
Hull, United Kingdom
|
| 33 |
NCT02925845 |
Recruiting |
Neuromuscular Electrostimulation in Radiocephalic Fistula |
|
- Device: Neuromuscular electrostimulation
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Radiocephalic fístula flow ( millimeters/minuts)
- Complications related to radiocephalic fistula: thrombosis, haematoma, stenosis, early failure, reintervention
|
34 |
All |
18 Years and older (Adult, Senior) |
NCT02925845 |
VES-COMPAVI-2014-01 |
NMS |
January 2015 |
November 2016 |
January 2017 |
October 6, 2016 |
October 6, 2016 |
|
- Lucía Inés Martínez Carnovale
Terrassa, Barcelona, Spain
|
| 34 |
NCT00522704 |
Unknown † |
Correlation Between Access Blood Flow and Extracorporeal Blood Flow |
|
- Other: Dynamic Arterial line Pressure (DALP)
|
Observational |
|
- Instituto Nacional de Cardiologia Ignacio Chavez
- JOSE CARRASCO ARTEAGA HOSPITAL FROM Ecuadorian Institute of Social Security
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
|
30 |
All |
18 Years to 80 Years (Adult, Senior) |
NCT00522704 |
INCich-07-08-7403 |
|
March 2008 |
April 2015 |
June 2015 |
August 30, 2007 |
November 6, 2014 |
|
- Instituto Nacional De Cardiología Ignacio Chávez
Mexico City, Distrito Federeal, Mexico
|
| 35 |
NCT02183194 |
Withdrawn |
Paclitaxel Coated PTA Balloons for Treatment of Dysfunctional AV Fistulae and Grafts |
- Dysfunctional AV Graft
- Dysfunctional AV Fistula
|
- Device: Lutonix Paclitaxel Drug Coated Balloon
|
Interventional |
Not Applicable |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Efficacy: Primary Patency
- Target Lesion Primary Patency (TLPP)
- Access circuit primary patency
- (and 5 more...)
|
0 |
All |
18 Years and older (Adult, Senior) |
NCT02183194 |
CL0021-01 |
ACCESS |
July 2014 |
December 2014 |
December 2014 |
July 8, 2014 |
February 2, 2016 |
|
- LKH-Univ. Klinikum Graz
Graz, Austria - Klinikum Klagenfurt am Wörthersee
Klagenfurt, Austria - Universitätsklinikum Köln AöR
Koln, Germany - Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Lubeck, Germany
|
| 36 |
NCT02106962 |
Completed
Has Results |
Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients |
|
- Drug: Topical Tranexamic Acid 5% with bacitracin
- Other: Topical Tranexamic Acid 25% with bacitracin
|
Interventional |
Phase 4 |
- California Institute of Renal Research
- Imprimis Pharmaceuticals, Inc.
|
Other / Industry |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Clotting TIme
- Local Infection
|
17 |
All |
18 Years and older (Adult, Senior) |
NCT02106962 |
001-Boiskin |
|
April 2014 |
August 2014 |
August 2014 |
April 8, 2014 |
September 25, 2017 |
September 25, 2017 |
- Fresenius Medical Care - Kearny Mesa
San Diego, California, United States - California Insitute of Renal Research
San Diego, California, United States - Fresenious Medical Care - Rancho
San Diego, California, United States
|
| 37 |
NCT03068845 |
Not yet recruiting |
Arteriovenous Fistula: Conventional Angioplasty vs Drug Eluting Balloon-assisted Maturation Intervention Clinical Trial |
- Stenosis of Arteriovenous Dialysis Fistula
|
- Device: Drug-eluting balloon angioplasty (DEBA)
- Device: Conventional Balloon Angioplasty (CBA)
|
Interventional |
Phase 3 |
- Singapore General Hospital
- Singapore Clinical Research Institute
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Fistula used successfully for haemodialysis (FUSH)
- Target lesion anatomic success
- Time from intervention to first successful haemodialysis with two-needle cannulation
- (and 11 more...)
|
124 |
All |
21 Years and older (Adult, Senior) |
NCT03068845 |
ACADEMIC_01 |
ACADEMIC |
June 2017 |
June 2019 |
March 2020 |
March 3, 2017 |
April 27, 2017 |
|
|
| 38 |
NCT03142360 |
Recruiting |
Effect of Beraprost Sodium (Berasil) on Hemodialysis |
- Arteriovenous Fistula Patency
|
- Drug: Beraprost sodium (Berasil)
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- AVF maturation rate
- Hemodialysis performed rate
- AVF failure rate
- Bleeding events
|
60 |
All |
19 Years to 79 Years (Adult, Senior) |
NCT03142360 |
4-2017-0129 |
|
April 5, 2017 |
April 4, 2019 |
April 4, 2019 |
May 5, 2017 |
May 5, 2017 |
|
- Division of Nephrology, Department of Internal Medicine Yonsei University College of Medicine
Seoul, Korea, Republic of
|
| 39 |
NCT03245944 |
Recruiting |
Optimal Timing of Percutaneous Intervention in Non-maturing Dialysis Fistulas |
- Immature Arteriovenous Fistula
|
- Procedure: early Angioplasty
- Procedure: late Angioplasty
|
Interventional |
Not Applicable |
- University of Alabama at Birmingham
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Fistula Maturity
- Fistula survival
- Fistula adequacy
|
112 |
All |
18 Years and older (Adult, Senior) |
NCT03245944 |
F0001 |
|
March 1, 2018 |
March 1, 2021 |
March 1, 2021 |
August 10, 2017 |
March 7, 2018 |
|
- UAB
Birmingham, Alabama, United States
|
| 40 |
NCT02814721 |
Completed |
Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique |
- Arteriovenous Fistula, Cannulation
|
- Device: Sonic Window ultrasound device
|
Interventional |
Not Applicable |
- Henry Ford Health System
- Analogic Corporation
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- infiltration due to dialysis access cannulation
- patient comfort
|
10 |
All |
18 Years to 80 Years (Adult, Senior) |
NCT02814721 |
9462 |
|
March 2015 |
August 2015 |
December 2015 |
June 28, 2016 |
June 28, 2016 |
|
- GHS West pavilion dialysis center
Detroit, Michigan, United States
|
| 41 |
NCT03077815 |
Not yet recruiting |
Systematically Intermittent Arm Exercise for Improving Maturation of Hemodialysis Arteriovenous Shunt: Study Protocol for a Randomized Controlled Trial |
- Systematically Intermittent Arm Exercise for Improving Maturation of Hemodialysis Arteriovenous Shunt
|
- Other: Systematically intermittent arm exercise
|
Interventional |
Not Applicable |
- National Taiwan University Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Other
|
- The diameter of each passage of the passage vein (forearm head vein) of the arterial and venous access within three months
|
150 |
All |
20 Years and older (Adult, Senior) |
NCT03077815 |
201701043RINC |
|
March 27, 2017 |
July 1, 2018 |
July 31, 2018 |
March 13, 2017 |
March 14, 2017 |
|
|
| 42 |
NCT01274117 |
Terminated |
Trial Comparing One-stage With Two-stage Basilic Vein Transposition |
- Brachiobasilic Arteriovenous Fistula
|
- Procedure: Transposition of the basilic vein and anastomosis with the brachial vein
|
Interventional |
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Maturation rate
- Long term primary, primary assisted and secondary patency
- Complication rate
- Basilic vein size
|
16 |
All |
18 Years to 90 Years (Adult, Senior) |
NCT01274117 |
2/20-4-10 |
|
December 2010 |
May 2014 |
May 2014 |
January 11, 2011 |
October 25, 2017 |
|
- University Hospital of Patras
Patras, Achaia, Greece
|
| 43 |
NCT03189667 |
Recruiting |
Drug Coated Balloons vs Plain Balloons for the Management of Dysfunctional Dialysis Fistula |
- Dysfunctional Dialysis Arteriovenous Fistula
|
- Device: Vessel preparation with angioplasty
- Device: Plain balloon angioplasty
- Device: Drug coated balloon angioplasty
|
Interventional |
Not Applicable |
- King Abdullah International Medical Research Center
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- AVF circuit patency
- Technical success
- Access circuit dysfunction free survival
- (and 2 more...)
|
92 |
All |
18 Years and older (Adult, Senior) |
NCT03189667 |
RC16/035/R |
|
October 15, 2017 |
January 15, 2019 |
January 15, 2019 |
June 16, 2017 |
December 20, 2017 |
|
- King ABdulaziz Medical City
Riyadh, Saudi Arabia
|
| 44 |
NCT03317821 |
Recruiting |
PHIL Evaluation in the Endovascular Treatment of Intracranial Dural AVF |
- Dural Arteriovenous Fistula
|
|
Observational |
|
- Microvention-Terumo, Inc.
- ClinSearch
|
Industry / Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Number of adverse events and assessment of neurological status at 1 month after each embolization
- Assessment of cure rate and of clinical course of the patient (stable /improvement /deteriorated)
- Number of adverse events and assessment of neurological status
- Improvement in the quality of life of the patient and changes in patients symptoms
|
60 |
All |
18 Years and older (Adult, Senior) |
NCT03317821 |
dAVF-Phil Registry |
|
September 18, 2017 |
September 2019 |
September 2019 |
October 23, 2017 |
November 6, 2017 |
|
- Rigshospitalet University
Copenhagen, Denmark - CHU Pellgrin
Bordeaux, France - Hôpital Bicêtre
Le Kremlin-Bicêtre, France - (and 13 more...)
|
| 45 |
NCT02628119 |
Recruiting |
Access Flow Based Intervention for Management of Arteriovenous Hemodialysis Access Dysfunction. |
- Hemodialysis Arteriovenous Fistula Maturation Failure
|
- Procedure: Intra-procedural access flow
- Procedure: Standard Angioplasty
|
Interventional |
Not Applicable |
- King Faisal Specialist Hospital & Research Center
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Primary un-assisted patency
- Secondary or assisted patency
- Number of procedures required in each group to maintain patency
|
140 |
All |
18 Years and older (Adult, Senior) |
NCT02628119 |
2151 040 |
FBI |
October 2015 |
October 2018 |
October 2018 |
December 11, 2015 |
October 4, 2016 |
|
- King Faisal Specialist Hospital & Research Center
Riyadh, Saudi Arabia
|
| 46 |
NCT00836862 |
Completed |
Arteriovenous Fistula Tissue Bank |
|
- Other: Biologic specimens
|
Observational |
|
|
Other |
- Observational Model: Other
- Time Perspective: Prospective
|
|
43 |
All |
19 Years and older (Adult, Senior) |
NCT00836862 |
482-08-EP |
|
February 1, 2009 |
November 10, 2012 |
September 7, 2017 |
February 4, 2009 |
February 5, 2018 |
|
- University of Nebraska Medical Center/The Nebraska Medical Center
Omaha, Nebraska, United States
|
| 47 |
NCT01382888 |
Terminated |
Efficacy and Local Tolerability of Topically Applied Heparin on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis |
|
- Drug: Heparin 2,400 IU /ml Cutaneous Spray
- Drug: Placebo Cutaneous Spray
|
Interventional |
Phase 2 |
- Cyathus Exquirere Pharmaforschungsgmbh
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Dialysis with a blood flow rate ≥ 300 ml/min OR, if the patient is not in need of dialysis, by combining the venous diameter > 0.4 cm and flow volume > 500ml/min assessed by duplex ultrasound, as well as via clinical impression
- Dialysis with a blood flow rate ≥ 300mL/min. If the patient is not in need of dialysis, by combining the venous diameter > 0.4 cm and flow volume > 500ml/min assessed by duplex ultrasound, as well as via clinical impression.
- The functional (unassisted) patency of AVF
- Local safety and tolerability profile of IMP by patients and investigator (Global assessment of tolerability)
|
30 |
All |
18 Years and older (Adult, Senior) |
NCT01382888 |
CYT/Heparin - 01/11
2011-000455-16 |
|
July 2011 |
April 2014 |
April 2014 |
June 27, 2011 |
May 8, 2014 |
|
- Krankenhaus der Elisabethinen Linz
Linz, Austria - Universitätsklinik für Innere Medizin III, Klinische Abteilung für Nephrologie und Dialyse, Medizinische Universität Wien
Vienna, Austria - 6. Medizinische Abteilung mit Nephrologie und Dialyse, Wilhelminenspital Wien
Vienna, Austria
|
| 48 |
NCT02962141 |
Recruiting |
A Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With APERTO |
- Peripheral Arterial Disease
- Fistula
|
- Device: Paclitaxel Releasing Peripheral Balloon Dilatation Catheter
- Device: Balloon Dilatation Catheter
|
Interventional |
Not Applicable |
- ZhuHai Cardionovum Medical Device Co., Ltd.
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Primary patency rate of the target lesion
- Device Success
- Technical Success
- (and 6 more...)
|
160 |
All |
18 Years to 75 Years (Adult, Senior) |
NCT02962141 |
APERTO-2015-01 |
|
October 2016 |
July 2018 |
July 2018 |
November 11, 2016 |
May 8, 2017 |
|
- Hainan General Hospital
Haikou, Hainan, China - The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China - The Third Xiangya Hospital of Central South University
Changsha, Hunan, China - (and 6 more...)
|
| 49 |
NCT01685710 |
Completed |
The Use of Glyceryl Trinitrate Patches in Arteriovenous Fistulas |
|
- Drug: GTN patch
- Drug: placebo comparator
|
Interventional |
Phase 4 |
- University Hospital Birmingham
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change to diameter of vein
- Number of participants with adverse events
|
200 |
All |
18 Years and older (Adult, Senior) |
NCT01685710 |
RRK4178 |
|
April 2013 |
May 2015 |
June 2015 |
September 14, 2012 |
June 2, 2015 |
|
- Queen Elizabeth Hospital, Birmingham.
Birmingham, West Midlands, United Kingdom
|
| 50 |
NCT02913274 |
Recruiting |
Arteriovenous Fistulae: Drug-eluting Balloon Angioplasty |
- Stenosis of Arteriovenous Dialysis Fistula
|
- Device: Paclitaxel (Taxol) eluting angioplasty balloon
- Device: high-pressure angioplasty balloon
- Device: low-pressure balloon
|
Interventional |
Not Applicable |
- Rennes University Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Number of patients whose haemodialysis is efficient at 1 year without needing further treatment of the stenotic site after initial angioplasty
|
262 |
All |
18 Years and older (Adult, Senior) |
NCT02913274 |
2016-A00420-51 |
FAVABED |
March 20, 2017 |
April 2020 |
April 2021 |
September 23, 2016 |
July 21, 2017 |
|
- Centre Hospitalier Universitaire de Caen
Caen, France - Centre Hospitalier de Charleville Mézières
Charleville Mézières, France - Centre Hospitalier Universitaire de Clermont-Ferrand
Clermont-Ferrand, France - (and 7 more...)
|
Create an RSS feed from your search for:
Download the search results for: